All Infectious Disease articles – Page 3
-
NewsAsk the expert: World Cup travel and Ebola risk
Luis Ostrosky, MD, division chief of infectious diseases at McGovern Medical School at UTHealth Houston and chief epidemiology officer for Memorial Hermann Health System addresses the Ebola outbreak in Congo and Uganda and how the United States could be affected through travel.
-
NewsLouse-borne relapsing fever: How the pathogen evades the immune system
A research team has now identified and characterized five closely related proteins that are crucial for the survival of Borrelia recurrentis in the human body. These so-called Chi proteins appear to have evolved from a common ancestor and are therefore considered homologous.
-
NewsPathogenic fungus transmitted by domestic cat scratches is present in wild animals
Researchers detected pathogenic species of Sporothrix in the internal organs of mammals, birds, and reptiles that were killed by vehicles on Brazilian roads. The study reveals a new reservoir for fungi and highlights the need for surveillance.
-
NewsAs California warms, cases of dengue fever are expected to grow
Historically, dengue fever has been rare in California. But according to new research, a warming climate is making parts of the state more hospitable to the illness — and the mosquitoes that carry it.
-
NewsClimate-driven dengue surge: Predicting future outbreak risk across Costa Rica
Scientists have developed a practical framework for predicting how shifting temperature and precipitation patterns could influence dengue fever outbreaks across Costa Rica.
-
NewsChina’s psittacosis knowledge gap: A scoping review calls for coordinated action
Psittacosis—a bacterial pneumonia transmitted from birds to humans—is experiencing a notable resurgence in China. A new review presents a sobering picture: psittacosis is epidemiologically substantive, clinically serious, and chronically underserved by institutional resources and public health infrastructure.
-
News Bruke showcases expanding Microbiology & Infection Diagnostics portfolio at ASM Microbe 2026
At ASM Microbe 2026, Bruker Corporation’s Microbiology & Infection Diagnostics (BMID) division demonstrated its expanding portfolio and innovations across microbial identification, sepsis diagnostics, molecular testing, and NGS workflows, advancing clinical research, and faster, actionable infectious disease diagnostics.
-
NewsNew antibiotic attacks bacteria in never-before-seen way
Scientists have discovered a new antibiotic that works in a never-before-seen way and may be the next frontliner in the fight against drug-resistant superbugs.
-
NewsStudy finds common infection does not increase risk of recurrent preterm birth
A new study has found that the common sexually transmitted infection, Mycoplasma genitalium, also known as MGen, does not appear to increase the risk of recurrent preterm birth. Earlier research suggested that certain Mycoplasma species might contribute to preterm labor, but those studies were limited.
-
NewsResearchers test two treatments to protect against deadly cattle disease
As cases of a deadly cattle disease rise in Arkansas, researchers are testing two treatments they hope will help ranchers protect their herds. The disease is bovine theileriosis and is caused by the parasite Theileria orientalis Ikeda, carried primarily by the invasive Asian longhorned tick.
-
NewsQ&A: Meet Letters in Applied Microbiology Junior Reviewer Md. Ekramul Karim
We caught up with Md Ekramul Karim, a Ph.D. candidate at the University of Houston, who is one of the newest Junior Reviewers with Letters in Applied Microbiology.
-
NewsFrom pest to useful tool: How wax moth larvae can help reduce animal testing in research
A new study indicates greater wax moth larvae show great potential as a robust and ethically acceptable in vivo model for studying pathogenic bacteria.
-
NewsFirst-in-human clinical trial shows promising results for new Lassa fever vaccine
Researchers have reported encouraging results from an early clinical trial that tested a new dual vaccine against Lassa fever and rabies. The study found that the vaccine was safe and induced immune responses against both viruses. There are currently no vaccines against Lassa fever on the market.
-
NewsShiga-producing E. coli infections are becoming more resistant to antibiotics
A new study indicates resistance to antimicrobial agents is rising among human infections with Shiga toxin–producing Escherichia coli bacteria.
-
NewsAccelerating chikungunya vaccine development in Africa: Launch of the ACT-CHIK Project
Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and prepare for the manufacturing of a chikungunya vaccine in Africa.
-
NewsEurope’s crops under threat: €6 million project launches to tackle rising plant pest crisis
The University of Warwick leads a European consortium to build the first platform capable of coordinating Europe’s response to devastating agricultural and forest pest invasions. The project will give plant health authorities the ability to model and optimise pest control strategies across the entire agri-value chain.
-
NewsResearch team awarded NIH grant to study early immune determinants of human tuberculosis infection
A research team was awarded a 5-year, $3.8 million grant to study early immune responses in the lung and how they influence tuberculosis infection outcomes. The program focuses on how lung immune cells called macrophages influence the earliest stages of tuberculosis infection.
-
NewsNew noninvasive tool may allow early detection of dangerous intestinal disease in premature babies
A first-in-human study shows that a handheld probe placed gently on the belly of most fragile infants can reliably identify early stages of necrotizing enterocolitis.
-
NewsMost cases of HIV persistence in blood following treatment explained by defective copies of the virus
A study based on blood samples strongly suggests that most persistent cases of viral detection, despite ideal HIV drug therapy, are not due to virus transmission or a rebound of active disease.
-
NewsNew study highlights maternal-fetal TORCH infection risk
Researchers have assessed long-term trends in TORCH infections in India, a region where reliable data have been lacking. TORCH includes pathogens that cause toxoplasmosis, rubella, cytomegalovirus (CMV), herpes simplex virus and other infections.